Company Filing History:
Years Active: 2016
Title: **Igor D'Angelo: Innovating Antibody Therapeutics**
Introduction
Igor D'Angelo, based in Port Moody, Canada, is a notable inventor in the field of biotechnology, particularly in the development of advanced antibody therapeutics. With a single patent to his name, he has made significant contributions to enhancing the efficacy of antibodies for medical applications.
Latest Patents
D'Angelo’s patent, titled "Antibodies with Enhanced or Suppressed Effector Function," focuses on rationally designed antibodies and polypeptides. These innovations incorporate multiple amino acid substitutions in the Fc region, aiming for a synergistic effect that increases both selectivity and binding affinity to target Fc receptors. This design makes the polypeptides more effective when used in antibody therapeutics compared to those that possess wild-type Fc components.
Career Highlights
Igor D'Angelo is associated with Zymeworks Inc., a firm known for its pioneering efforts in drug discovery and development. His role at Zymeworks has allowed him to leverage his research insights to propel advancements in antibody technology.
Collaborations
Throughout his career, D'Angelo has worked alongside talented individuals such as Dustin Bleile and Stacey A. L. Tom-Yew. These collaborations have contributed to the creation of innovative solutions in the biotech sector, enhancing the potential of novel therapeutic antibodies.
Conclusion
Igor D'Angelo stands out as an influential inventor whose work in antibody therapeutics not only advances the scientific community's understanding but also holds promise for transformative healthcare solutions. His patent highlights a commitment to innovative design in biopharmaceuticals, underscoring the role of inventors in shaping the future of medicine.